Tetratherix Ltd. raised AU$45 million (US$25 million) in its IPO on the Australian Securities Exchange (ASX:TTX) to support clinical development of its Tetramatrix polymer biomaterial platform to support bone regeneration, tissue spacing and tissue healing.
Med-tech firms raising money in public or private financings, including: Calmwave, Hapbee Technologies, Icon Group, Siemens Healthineers, Varian Medical Systems.
Ophthalmology company Polyactiva Pty Ltd closed a AU$40 million (US$25 million) series C round to advance late-stage clinical trials in the U.S. of its lead candidate, PA-5108.
Med-tech firms raising money in public or private financings, including: Elfie, Empo Health, Icecure Medical, Lifeward, Nephrolytics, Trisalus Life Sciences.
RSS
